GLMD icon

Galmed Pharmaceuticals

34 hedge funds and large institutions have $60.6M invested in Galmed Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
-8
Holders Change %
-19.05%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
7
Reduced
9
Closed
13
Calls
Puts
$111K
Net Calls
-$111K
Net Calls Change
-$72K
Name Holding Trade Value Shares
Change
Shares
Change %
US Bancorp
26
US Bancorp
Minnesota
$19K
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
$8.17K
Bank of America
28
Bank of America
North Carolina
$8K +$8K +6 New
TRCT
29
Tower Research Capital (TRC)
New York
$5K +$5K +3 New
SWM
30
SeaCrest Wealth Management
New York
$4K
CG
31
Cutler Group
California
$3K -$40.5K -27 -93%
Simplex Trading
32
Simplex Trading
Illinois
$3K +$3K +2 New
RFA
33
Reilly Financial Advisors
California
$2K
FHA
34
Flagship Harbor Advisors
Massachusetts
$2K
UOC
35
UBS O'Connor
Illinois
-$726K -591 Closed
SIM
36
Spark Investment Management
New York
-$507K -413 Closed
PAM
37
Premier Asset Management
Illinois
-$505K -411 Closed
MC
38
Menta Capital
California
-$239K -194 Closed
OAM
39
Oxford Asset Management
United Kingdom
-$220K -179 Closed
Millennium Management
40
Millennium Management
New York
-$141K -115 Closed
Squarepoint
41
Squarepoint
New York
-$110K -89 Closed
Northern Trust
42
Northern Trust
Illinois
-$83K -68 Closed
MWNA
43
Marshall Wace North America
New York
-$46K -38 Closed
BlackRock
44
BlackRock
New York
-$33K -26 Closed
DWA
45
Dorsey Wright & Associates
California
-$10K -8 Closed
UBS Group
46
UBS Group
Switzerland
-$4K -3 Closed
Barclays
47
Barclays
United Kingdom
-$2K -2 Closed